newwin
Luciann Nguyen
Settings
← Accounts
academic

University of Pennsylvania

64
Account opportunity
Not established
Relationship
1
Active signals
1
Trials as sponsor

Why this account matters

University of Pennsylvania

New trial — TCR1188-ABC Cells in KRAS-mutated Cancers

New trialNCT07594067
64/100
Opportunity
Commercial fit17/25
Clinical timing20/20
Biomarker need10/20
Relationship2/10
Signal strength9/10
Account value5/10
Urgency1/5

New phase 1 trial NCT07594067 posted by University of Pennsylvania: "TCR1188-ABC Cells in KRAS-mutated Cancers". New trial on a phase 1 recruiting study is a moment when external vendors are commonly selected or expanded (spec §70).

Why nowClinicalTrials.gov record updated 33 days ago.

ConfidenceHigh · 95%clinical development · translational medicine · clinical operations

NextMap clinical development and translational medicine stakeholders on the sponsor, confirm no colleague is mid-conversation, then draft evidence-based outreach.

Trials

TrialPhaseTesting language
NCT07594067
TCR1188-ABC Cells in KRAS-mutated Cancers
phase 1
mol. elig.